CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 86 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,662 | +288.7% | 1,997 | +157.7% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 775 | +84.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 420 | +5.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 400 | +555.7% | 0.00% | – |
| Q3 2018 | $1,000 | -99.9% | 61 | -99.9% | 0.00% | – |
| Q4 2016 | $1,029,000 | +19.8% | 100,000 | +17.7% | 0.00% | – |
| Q3 2016 | $859,000 | +38.5% | 84,944 | +54.0% | 0.00% | – |
| Q2 2016 | $620,000 | -81.9% | 55,175 | -69.5% | 0.00% | – |
| Q4 2015 | $3,432,000 | +3.9% | 180,925 | +2.8% | 0.00% | – |
| Q3 2015 | $3,302,000 | +671.5% | 175,925 | +418.1% | 0.00% | – |
| Q3 2014 | $428,000 | – | 33,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |